Search for: "Bausch "
Results 21 - 40
of 358
Sort by Relevance
|
Sort by Date
18 Jan 2022, 11:12 am
Bausch + Lomb is returning to the public markets in an IPO expected to rank among the biggest in healthcare. [read post]
14 Dec 2021, 2:00 pm
(Note: in July 2018 – almost three years after the shareholder class actions commenced – the company changed its name to Bausch Health Companies, Inc.) [read post]
13 Sep 2021, 7:50 am
Bausch to pay $300 mln in antitrust suit over diabetes drug. [read post]
23 Jul 2021, 9:22 am
This techtalk will feature: Expansion to Canada through the ‘Start-up Visa Program Canada’ and funding opportunities for Colombian Startups.By Stuart Browne, CEO Pycap Venture Capital.General considerations on starting operations in Canada.By: Jeff Chorlton, Presidetn & CEO, Flexserv.Types of business structures, legislation, and other legal considerations.By: Tanya Kuzman, Associate Lawyer, Mills & Mills LLP.Tax Planning, compliance, and other accounting considerations.By:… [read post]
21 Jul 2021, 8:04 am
“Connecticut Top Court Asked to Clarify Law in Bausch & Lomb Case”: Julie Steinberg of Bloomberg Law has this report (subscription required for full access) on a decision that the U.S. [read post]
18 Jun 2021, 7:47 am
Case Summary The underlying litigation arose out of allegations that Valeant Pharmaceuticals, now known as Bausch Health Companies, misled shareholders about price gouging, kickbacks, a secret “captive” pharmacy network, and engaged in other deceptive business strategies. [read post]
15 Jan 2021, 1:48 pm
Bausch Health (formerly Valeant Pharmaceuticals) – In yet another case of accounting fraud, the SEC obtained a $45 million penalty from Bausch Health, formerly known as Valeant Pharmaceuticals, to resolve charges that its executives engaged in improper revenue recognition and misleading disclosures in SEC filings and earnings presentations. [read post]
10 Dec 2020, 2:46 pm
Bausch & Lomb, Inc., 115 F.R.D. 308 (N.D. [read post]
10 Dec 2020, 2:46 pm
Bausch & Lomb, Inc., 115 F.R.D. 308 (N.D. [read post]
8 Dec 2020, 4:07 pm
” 3) The EPO’s Ride from Patentamt to Oktroybureau by Thorsten Bausch “The official translation of “European Patent Office” into German is “Europäisches Patentamt”, the latter obviously being a composite of Patent and Amt.The German word “Amt” is derived from medieval German “ambt” or “ambahte“, which means servant. [read post]
8 Dec 2020, 6:28 am
” 3) The EPO’s Ride from Patentamt to Oktroybureau by Thorsten Bausch “The official translation of “European Patent Office” into German is “Europäisches Patentamt”, the latter obviously being a composite of Patent and Amt.The German word “Amt” is derived from medieval German “ambt” or “ambahte“, which means servant. [read post]
9 Oct 2020, 1:48 pm
In an earlier post on this blog, “The German UPCA Ratification – at Schweinsgalopp towards Mautdebakel”, Thorsten Bausch, partner of Hoffmann Eitle, lashed out at the German Ministry of Justice and Consumer Protection and the European Commission for rushing through and supporting the rapid re-ratification of the UPCA. [read post]
31 Jul 2020, 2:09 pm
The Securities and Exchange Commission today announced that Bausch Health, formerly Quebec, Canada-based Valeant Pharmaceuticals, agreed to pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures in SEC…Read the Full Press ReleaseHave a securities law question? [read post]
8 Jul 2020, 9:32 am
Some of the petitions challenging the Magnetar Capital-backed Neodron were instituted this week, the same week a tranche of Magnetar’s Data Scape patents were affirmed unpatentable on Section 101 before the Federal Circuit; further Bausch & Lomb abbreviated new drug application (ANDA)-related suits were filed as discussed last week; and new and old-hand IP Edge subs continue to file at a brisk clip. [read post]
2 Jul 2020, 9:15 am
This week included Amazon filing four petitions against Freshub scanner patents; Verizon filed a number of petitions against Huawei, presumably in response to their widely publicized billion-dollar licensing demands; Dolby filed against Intertrust patents; there was plenty of continued IP Edge activity; but otherwise, a relatively quiet week; that said, the following week’s numbers (which stop at Monday’s reporting) contain a slew of new cases by Bausch and Lomb, as well as a… [read post]
29 May 2020, 11:42 am
Johnson & Johnson’s decision to stop selling this product came months after Bausch Health Cos. announced it would stop selling its talc product Shower to Shower. [read post]
11 Mar 2020, 1:19 pm
The report notes that 2019 was a “relatively slow year” in terms of overall settlement recoveries, 2020 will likely be a more active, as there are at least two billion plus securities class action settlements in the pipeline that likely will be finalized in 2020: Valeant Pharmaceuticals (now Bausch Health Companies, Inc.) for $1.2 billion; and American Realty Capital Properties (now Vereit) at $1 billion. [read post]
25 Feb 2020, 8:49 am
” “Bausch & Lomb is both an indirect subsidiary of Valeant-CA and an affiliate of Salix. [read post]
24 Feb 2020, 2:36 am
by Sabine Möhle, Klemens Stratmann and Thorsten Bausch Decision T 1621/16 of Technical Board of Appeal 3.3.06 deals with a patent concerning a liquid hand dishwashing detergent composition. [read post]
23 Feb 2020, 4:00 am
Bausch Health Companies Inc., 2020 QCCS 275Juridiction : Cour supérieure (C.S.), MontréalDécision de : Juge Peter KalichmanDate : 3 février 2020 VALEURS MOBILIÈRES — divers — procédure — autorisation d’une demande en justice — responsabilité civile — société par actions — marché secondaire — fausses déclarations — prescription extinctive —… [read post]
